Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
57 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
−1 pts over 3 months50% of OMER’s tracked signals bullish
FundamentalsNeutral
TechnicalsNeutral
Alternative dataBullish
SentimentNeutral
Price$19.12
Year Range$8.67 – $21.05
Market Cap$1.36B
PE Ratio15.37
IndustryBiotechnology

What Is Omeros’s AI Stock Analysis?

Omeros’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Omeros’s momentum in near-real time.

Omeros (OMER) has an AltIndex AI Score of 57/100, currently a Hold signal. The AI Score distills Omeros's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Omeros’s Full AI Analysis

Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics for inflammation, coagulopathies, and disorders of the central nervous system. The company's pipeline includes both clinical and preclinical programs. Omeros is perhaps best known for Omidria, a cataract surgery drug, and OMS721 (narsoplimab), an anti-MASP-2 monoclonal antibody being researched for various orphan indications.

Fundamental Analysis

For the last quarter, Omeros reported a net income of $13 million. This signifies a 76.40% decrease compared to the preceding quarter, indicating a concerning trend in profitability. However, comparing the same quarter last year, there’s a 152.05% increase in net income, suggesting robust year-over-year growth.

Premium

Keep reading AltIndex’s full AI analysis of Omeros — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving OMER’s AI Score?

Fundamentals

Net income for the last quarter was $13M. This represents a decrease of 76.40% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -152.05%, suggesting positive year-over-year growth. Ebitda for the last quarter was $74,000. This represents a decrease of 99.87% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -100.29%, suggesting positive year-over-year growth. The current P/E ratio is 15.37. This appears to be within a normal range, neither particularly high nor low. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.

See Omeros’s earnings and insider transactions.

Technicals

Today's stock price is $19.12. This represents a decrease of 1.39% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 356.32%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $18.77, which is lower than the previous SMA10 of $18.79. This suggests a potential downward trend in price movement. The RSI is 67.6, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

Omeros has an estimated 22 open positions. This number is up by 1000% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Omeros is neutral. Omeros has an estimate of 7,000 visitors to their webpage. The number of visitors is up by 17% in the last couple of months, a bullish trend as this can indicate can increase in customers.

Explore Omeros’s job postings, web traffic and app downloads.

Frequently Asked Questions: Omeros AI Stock Analysis

Omeros's AltIndex AI Score is 57/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Omeros a Hold (57/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Omeros — company overview, fundamentals, technicals and alternative data, with a recommendation. See the OMER AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.